MedPath

Study to Determine the Effect of Trucrose in Patients with Type II Diabetes Mellitus

Not Applicable
Completed
Conditions
Health Condition 1: E119- Type 2 diabetes mellitus without complications
Registration Number
CTRI/2020/07/026346
Lead Sponsor
Trulit Herbals
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Adult, both male and female patients with Type 2 DM with fasting blood sugar between 120 and 200mg/dL

2.Those who are not avoiding oral intake of sugar

3.Be geographically accessible for follow up

4.Ability to understand and the willingness to sign and date a written informed consent document at the screening visit before any protocol specific procedures are performed

Exclusion Criteria

1.Preganancy or child bearing ptetntial who are at risk of pregancy

2.Patients with recent stroke or heart attack

3.Fasting blood sugar >200mg/dL

4.Limited life expectancy

5.Patients with rasied Blood Urea and Cretainine or clinical suspicion of Diabetic Neuropathy

6.Recent minor/major surgeries

7.Alcoholic subjects

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in the HbA1C (%) from baseline to end of studyTimepoint: Baseline and End of the Study
Secondary Outcome Measures
NameTimeMethod
Change in Serum insulin levels from baseline to end of the studyTimepoint: Baseline and End of the Study;Change in the lipid variables (TC, TG, LDL-C, HDL-C)Timepoint: Baseline and End of the Study;Changes in FPG and 2 hr PPG from baseline to end of the studyhTimepoint: Baseline, Week-2, week-4, week-8 and week-12
© Copyright 2025. All Rights Reserved by MedPath